The Cigna Group with ticker code (CI) have now 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $438.00 and $355.00 and has a mean share price target at $398.38. (at the time of writing). Now with the previous closing price of $332.04 this is indicating there is a potential upside of 20.0%. The 50 day MA is $339.49 while the 200 day moving average is $341.77. The total market capitalization for the company now stands at 90.09B. The price for the stock stands currently at: $323.88 USD
The potential market cap would be $108,086,821,655 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 30.67, revenue per share of $808.02 and a 2.8% return on assets.
The Cigna Group is a global health services company. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.
